Literature DB >> 27429052

Plasma biomarkers to study mechanisms of liver injury in patients with hypoxic hepatitis.

James L Weemhoff1, Benjamin L Woolbright1, Rosalind E Jenkins2, Mitchell R McGill1, Matthew R Sharpe3, Jody C Olson3, Daniel J Antoine2, Steven C Curry4,5, Hartmut Jaeschke1.   

Abstract

BACKGROUND & AIMS: Hypoxic hepatitis is a clinical condition precipitated by prolonged periods of oxygen deprivation to the liver. It can have several underlying causes. Despite its prevalence in critically ill patients, which can reach upwards of 10%, very little is known about the mechanisms of injury. Thus, we set out to measure previously identified circulating biomarkers in an attempt to describe mechanisms of injury following hypoxic hepatitis.
METHODS: Plasma from patients diagnosed with hypoxic hepatitis was collected for this study. Biomarkers of hepatocellular injury, mitochondrial damage and cell death were measured. These results were compared against results obtained from well-characterized acetaminophen overdose patients.
RESULTS: At peak injury, ALT measured 4082±606 U/L and gradually decreased over 5 days, corresponding to the clinically observed pattern of hypoxic hepatitis. Levels of GDH showed a similar pattern, but neither ALT nor GDH were significantly higher in these patients than in acetaminophen patients. Plasma levels of DNA fragments mimicked hepatocellular injury as measured by ALT and miRNA-122. Interestingly, we found a significant increase in caspase-cleaved cytokeratin-18; however, the full-length form greatly exceeded the cleaved form at the time of maximum injury (45837±12085 vs 2528±1074 U/L). We also found an increase in acHMGB1 at later time points indicating a possible role of inflammation, but cytokine levels at these times were actually decreased relative to early time points.
CONCLUSIONS: The mechanism of injury following hypoxic hepatitis involves mitochondrial damage and DNA fragmentation. Importantly, necrosis, rather than apoptosis, is the main mode of cell death.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Hypoxic hepatitis; acetaminophen; apoptosis; biomarkers; ischaemic hepatitis; miRNA-122; necrosis

Mesh:

Substances:

Year:  2016        PMID: 27429052      PMCID: PMC5243938          DOI: 10.1111/liv.13202

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  36 in total

1.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 2.  Liver dysfunction in critical illness.

Authors:  F Hawker
Journal:  Anaesth Intensive Care       Date:  1991-05       Impact factor: 1.669

3.  Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.

Authors:  Benjamin L Woolbright; Kenneth Dorko; Daniel J Antoine; Joanna I Clarke; Parviz Gholami; Feng Li; Sean C Kumer; Timothy M Schmitt; Jameson Forster; Fang Fan; Rosalind E Jenkins; B Kevin Park; Bruno Hagenbuch; Mojtaba Olyaee; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-28       Impact factor: 4.219

Review 4.  Hypoxic hepatitis - epidemiology, pathophysiology and clinical management.

Authors:  Valentin Fuhrmann; Bernhard Jäger; Anna Zubkova; Andreas Drolz
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

5.  Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans.

Authors:  C David Williams; Mary Lynn Bajt; Matthew R Sharpe; Mitchell R McGill; Anwar Farhood; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2014-01-15       Impact factor: 4.219

6.  Effect of anoxia on intracellular ATP, Na+i, Ca2+i, Mg2+i, and cytotoxicity in rat hepatocytes.

Authors:  A Gasbarrini; A B Borle; H Farghali; C Bender; A Francavilla; D Van Thiel
Journal:  J Biol Chem       Date:  1992-04-05       Impact factor: 5.157

7.  Role of pH in protection by low sodium against hypoxic injury in isolated perfused rat livers.

Authors:  Mariapia Vairetti; Plinio Richelmi; Francantonio Bertè; Robert T Currin; John J Lemasters; Roberto Imberti
Journal:  J Hepatol       Date:  2005-09-15       Impact factor: 25.083

8.  Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis.

Authors:  Jeanine Ward; Chitra Kanchagar; Isana Veksler-Lublinsky; Rosalind C Lee; Mitchell R McGill; Hartmut Jaeschke; Steven C Curry; Victor R Ambros
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

Review 9.  Hypoxic liver injury and cholestasis in critically ill patients.

Authors:  Thomas Horvatits; Michael Trauner; Valentin Fuhrmann
Journal:  Curr Opin Crit Care       Date:  2013-04       Impact factor: 3.687

10.  Myeloid knockout of HIF-1 α does not markedly affect hemorrhage/resuscitation-induced inflammation and hepatic injury.

Authors:  G Wetzel; B Relja; A Klarner; D Henrich; N Dehne; B Brühne; M Lehnert; I Marzi
Journal:  Mediators Inflamm       Date:  2014-06-01       Impact factor: 4.711

View more
  15 in total

1.  Cell Death and Prognosis of Mortality in Alcoholic Hepatitis Patients Using Plasma Keratin-18.

Authors:  Benjamin L Woolbright; Brian W Bridges; Winston Dunn; Jody C Olson; Steven A Weinman; Hartmut Jaeschke
Journal:  Gene Expr       Date:  2017-08-03

2.  Mechanistic identification of biofluid metabolite changes as markers of acetaminophen-induced liver toxicity in rats.

Authors:  Venkat R Pannala; Kalyan C Vinnakota; Kristopher D Rawls; Shanea K Estes; Tracy P O'Brien; Richard L Printz; Jason A Papin; Jaques Reifman; Masakazu Shiota; Jamey D Young; Anders Wallqvist
Journal:  Toxicol Appl Pharmacol       Date:  2019-04-08       Impact factor: 4.219

3.  Acetaminophen Hepatotoxicity.

Authors:  Anup Ramachandran; Hartmut Jaeschke
Journal:  Semin Liver Dis       Date:  2019-03-08       Impact factor: 6.115

4.  Is Keratin-18 only a Marker of Cell Death in Acute-On-Chronic Liver Failure?

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  J Lab Precis Med       Date:  2018-03-20

5.  The Relationship Between Circulating Acetaminophen-Protein Adduct Concentrations and Alanine Aminotransferase Activities in Patients With and Without Acetaminophen Overdose and Toxicity.

Authors:  Steven C Curry; Angela Padilla-Jones; Anne-Michelle Ruha; Ayrn D O'Connor; A Min Kang; Diana G Wilkins; Hartmut Jaeschke; Kelly Wilhelms; Richard D Gerkin
Journal:  J Med Toxicol       Date:  2019-04-12

Review 6.  Biomarkers of drug-induced liver injury.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Adv Pharmacol       Date:  2019-03-06

7.  Redrawing the map to novel DILI biomarkers in circulation: Where are we, where should we go, and how can we get there?

Authors:  Joel H Vazquez; Mitchell R McGill
Journal:  Livers       Date:  2021-12-01

8.  Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores.

Authors:  Na-Ling Kang; Qing-Fa Ruan; De-Sheng Zhang; Xue-Ping Yu; Zhen-Ting Hu; Zhi-Min Lin; Lu-Ying Wu; Meng-Xin Lin; Zu-Xiong Huang; Jia-Ji Jiang; Yu-Rui Liu; Ri-Cheng Mao; Da-Wu Zeng
Journal:  J Clin Transl Hepatol       Date:  2022-06-01

Review 9.  Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Expert Rev Mol Diagn       Date:  2018-08-13       Impact factor: 5.225

Review 10.  The past and present of serum aminotransferases and the future of liver injury biomarkers.

Authors:  Mitchell R McGill
Journal:  EXCLI J       Date:  2016-12-15       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.